Targeting the ERK2 D-Recruitment Site with Anticancer Peptides from the DRAMP Database: An Integrated In Silico Study
International Journal of Molecular Sciences · 2026
DOI: 10.3390/ijms27219532 ↗Kurz gefasst
Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2026. Verfasst von Nahlah Makki Almansour und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, College of Science, University of Hafr Al Batin, Hafr Al Batin 1803, Saudi Arabia. Hauptthemen laut MEDLINE: Mitogen-Activated Protein Kinase 1, Peptides, Antineoplastic Agents. Die Arbeit nennt 67 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Deputyship for Research & Innovation, Ministry of Education.
Abstract (Originalsprache)
ERK2 is a central regulator of the MAPK pathway, governing cell proliferation, differentiation, and survival, and its aberrant activation is a recognized driver of cancer progression. ATP-competitive ERK2 inhibitors suffer from limited selectivity owing to the highly conserved kinase active site, whereas the ERK2 D-recruitment site (DRS), a non-catalytic docking surface mediating substrate recruitment, offers a more selective route to pathway modulation. Herein, the DRAMP database was screened, yielding 31 peptides with putative anticancer activity within the 5–15 residue range, which were docked towards the ERK2 DRS employing HADDOCK2.4. The protocol was first validated by reproducing the crystallographic binding mode of the co-crystallized KIM-MAP3 peptide. Peptides meeting the applied docking-score threshold were advanced to molecular dynamics simulations, followed by MM-GBSA binding energy calculations. Over 200 ns trajectories, DRAMP03987, DRAMP03983, and DRAMP03985 bound ERK2 more favorably than the reference KIM-MAP3 peptide, with ΔGbinding values of −71.2, −65.1, and −63.1 kcal/mol, respectively, versus −51.5 kcal/mol. Energetic and structural analyses indicated sustained occupancy of the DRS throughout the simulations, while in silico physicochemical profiling revealed preliminary physicochemical characteristics. Collectively, these findings highlight the potential of the identified peptides as ERK2 DRS-binding candidates, warranting further experimental investigation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biology, College of Science, University of Hafr Al Batin, Hafr Al Batin 1803, Saudi Arabia.
- Computational Chemistry Laboratory, Chemistry Department, Faculty of Science, Minia University, Minia 61519, Egypt.
- School of Health Sciences, University of KwaZulu-Natal, Westville Campus, Durban 4000, South Africa.
- Department of Supportive Requirements, University of Technology and Applied Sciences, Nizwa 611, Oman.
ORCID-Profile: Nahlah Makki Almansour, Mahmoud A A Ibrahim
Förderung
- Deputyship for Research & Innovation, Ministry of Education
Zitieren
APA
Almansour, N. M., & Ibrahim, M. A. A. (2026). Targeting the ERK2 D-Recruitment Site with Anticancer Peptides from the DRAMP Database: An Integrated In Silico Study. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27219532
Vancouver
Almansour NM, Ibrahim MAA. Targeting the ERK2 D-Recruitment Site with Anticancer Peptides from the DRAMP Database: An Integrated In Silico Study. International Journal of Molecular Sciences. 2026. doi:10.3390/ijms27219532
BibTeX
@article{Almansour2026,
author = {Almansour, Nahlah Makki and Ibrahim, Mahmoud A A},
title = {Targeting the ERK2 D-Recruitment Site with Anticancer Peptides from the DRAMP Database: An Integrated In Silico Study},
journal = {International Journal of Molecular Sciences},
year = {2026},
doi = {10.3390/ijms27219532}
}
EUVIMED